TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
LobSor Pharmaceuticals AB
Closing information (x1000 SEK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover | 12,465 | 37,569 | 25,456 |
Financial expenses | 13 | 103 | 237 |
Earnings before taxes | 36,677 | 47,835 | -27,375 |
EBITDA | 35,991 | 56,960 | -16,282 |
Total assets | 106,968 | 73,860 | 62,244 |
Current assets | 73,048 | 33,658 | 14,098 |
Current liabilities | 16,667 | 759 | 39,036 |
Equity capital | 90,301 | 73,101 | 21,097 |
- share capital | 50 | 50 | 50 |
Employees (average) | 3 | 3 | 1 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency | 84.4% | 99.0% | 33.9% |
Turnover per employee | 4,155 | 12,523 | 25,456 |
Profit as a percentage of turnover | 294.2% | 127.3% | -107.5% |
Return on assets (ROA) | 34.3% | 64.9% | -43.6% |
Current ratio | 438.3% | 4434.5% | 36.1% |
Return on equity (ROE) | 40.6% | 65.4% | -129.8% |
Change turnover | -25,104 | 12,113 | 17,611 |
Change turnover % | -67% | 48% | 224% |
Chg. No. of employees | 0 | 2 | 0 |
Chg. No. of employees % | 0% | 200% | 0% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.